Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
AGM
|
James R Engebretsen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 168 Added 1.27% |
$18,225
$108.48 p/Share
|
Mar 31
2022 |
|
AGM
|
Marc J Crady
SVP - Chief Credit Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 149 Reduced 6.2% |
$16,546
$111.05 p/Share
|
Mar 31
2022 |
|
AGM
|
Zachary Carpenter
EVP - Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 682 Reduced 8.46% |
$75,736
$111.05 p/Share
|
Mar 31
2022 |
|
AGM
|
Brian M Brinch
EVP - Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 517 Reduced 5.8% |
$57,413
$111.05 p/Share
|
Mar 31
2022 |
|
RFP
|
Jennifer C Dolan
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 14,893 Reduced 22.94% |
$205,672
$13.81 p/Share
|
Mar 31
2022 |
|
RFP
|
Jennifer C Dolan
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 14,893 Added 18.66% |
-
|
Mar 31
2022 |
|
LAW
|
Michael Lafair
EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,014 Reduced 0.26% |
$34,446
$33.97 p/Share
|
Mar 31
2022 |
|
ZUO
|
Robert J. Traube
Chief Revenue Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 31,250 Added 38.34% |
-
|
Mar 31
2022 |
|
ZUO
|
Todd Mc Elhatton
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 28,125 Added 27.81% |
-
|
Mar 31
2022 |
|
ZUO
|
Tien Tzuo
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 12,500 Reduced 100.0% |
$188,625
$15.09 p/Share
|
Mar 31
2022 |
|
ZUO
|
Tien Tzuo
Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 12,500 Added 50.0% |
-
|
Mar 31
2022 |
|
ZUO
|
Sri Srinivasan
Chief Product & Tech Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 17,500 Added 39.68% |
-
|
Mar 31
2022 |
|
MIR
|
John W Kuo
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,611 Added 23.65% |
-
|
Mar 31
2022 |
|
MIR
|
Steven W. Etzel
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,611 Added 23.65% |
-
|
Mar 31
2022 |
|
MIR
|
Kenneth Bockhorst
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,309 Added 22.13% |
-
|
Mar 31
2022 |
|
MIR
|
Jody Markopoulos
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,309 Added 22.13% |
-
|
Mar 31
2022 |
|
CGC
|
Theresa Yanofsky
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 670 Reduced 6.6% |
$6,459
$9.64 p/Share
|
Mar 31
2022 |
|
CGC
|
David Angelo Lazzarato
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 673 Reduced 14.18% |
$6,488
$9.64 p/Share
|
Mar 31
2022 |
|
DCOM
|
Stuart H Lubow
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 5,264 Added 2.34% |
-
|
Mar 31
2022 |
|
DCOM
|
Avinash Reddy
SEVP - CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 2,024 Added 4.43% |
-
|
Mar 31
2022 |
|
DCOM
|
Kevin M O'Connor |
BUY
Grant, award, or other acquisition
|
Direct | 6,768 Added 2.47% |
-
|
Mar 31
2022 |
|
DCOM
|
Christopher J Porzelt
Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,344 Added 6.61% |
-
|
Mar 31
2022 |
|
DCOM
|
Patricia M Schaubeck
EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 1,518 Added 5.44% |
-
|
Mar 31
2022 |
|
DCOM
|
Conrad J Gunther Jr
Chief Lending Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,781 Added 2.51% |
-
|
Mar 31
2022 |
|
MODV
|
Frank J Wright
Director |
BUY
Grant, award, or other acquisition
|
Direct | 116 Added 0.74% |
$13,385
$115.39 p/Share
|
Mar 31
2022 |
|
MODV
|
Stacy Saal
Director |
BUY
Grant, award, or other acquisition
|
Direct | 200 Added 7.55% |
$23,078
$115.39 p/Share
|
Mar 31
2022 |
|
MODV
|
David A Coulter
Director |
BUY
Grant, award, or other acquisition
|
Direct | 200 Added 0.83% |
$23,078
$115.39 p/Share
|
Mar 31
2022 |
|
MODV
|
Rahul D Samant
Director |
BUY
Grant, award, or other acquisition
|
Direct | 216 Added 8.74% |
$24,924
$115.39 p/Share
|
Mar 31
2022 |
|
ENVX
|
Betsy S Atkins
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,054 Added 0.55% |
-
|
Mar 31
2022 |
|
ENVX
|
Pegah Ebrahimi
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,135 Added 50.0% |
-
|
Mar 31
2022 |
|
ENVX
|
Emmanuel T Hernandez
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,054 Added 0.23% |
-
|
Mar 31
2022 |
|
ENVX
|
J Daniel Mccranie
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,054 Added 0.22% |
-
|
Mar 31
2022 |
|
ENVX
|
Gregory Reichow
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,054 Added 25.0% |
-
|
Mar 31
2022 |
|
ENVX
|
Thurman J Rodgers
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,054 Added 25.0% |
-
|
Mar 31
2022 |
|
BV
|
James R Abrahamson |
BUY
Grant, award, or other acquisition
|
Direct | 1,790 Added 2.05% |
$24,362
$13.61 p/Share
|
Mar 31
2022 |
|
BV
|
Richard Roedel |
BUY
Grant, award, or other acquisition
|
Direct | 1,836 Added 3.18% |
$24,988
$13.61 p/Share
|
Mar 31
2022 |
|
BV
|
Francisco Lopez Jr. |
BUY
Grant, award, or other acquisition
|
Direct | 1,699 Added 19.02% |
$23,123
$13.61 p/Share
|
Mar 31
2022 |
|
BV
|
Jane L Okun Bomba |
BUY
Grant, award, or other acquisition
|
Direct | 1,836 Added 4.11% |
$24,988
$13.61 p/Share
|
Mar 31
2022 |
|
BV
|
Mara E Swan |
BUY
Grant, award, or other acquisition
|
Direct | 1,745 Added 3.99% |
$23,749
$13.61 p/Share
|
Mar 31
2022 |
|
PRCT
|
Hisham Shiblaq
EVP, Chief Comm. Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,914 Added 7.57% |
$114,993
$29.38 p/Share
|
Mar 31
2022 |
|
PRCT
|
Kevin Waters
EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct | 7,914 Added 11.56% |
$232,513
$29.38 p/Share
|
Mar 31
2022 |
|
PRCT
|
Reza Zadno
President, CEO |
BUY
Grant, award, or other acquisition
|
Direct | 39,312 Added 29.2% |
$1,154,987
$29.38 p/Share
|
Mar 31
2022 |
|
PRCT
|
Alaleh Nouri
EVP, CLO, CORP. SEC. |
BUY
Grant, award, or other acquisition
|
Direct | 3,404 Added 6.83% |
$100,010
$29.38 p/Share
|
Mar 31
2022 |
|
RXRX
|
Ramona Doyle
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 9,072 Added 6.92% |
$22,499
$2.48 p/Share
|
Mar 31
2022 |
|
SAH
|
O Bruton Smith
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 5,626 Reduced 0.57% |
$239,161
$42.51 p/Share
|
Mar 31
2022 |
|
SAH
|
David Bruton Smith
Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 7,637 Reduced 1.61% |
$324,649
$42.51 p/Share
|
Mar 31
2022 |
|
SAH
|
Jeff Dyke
President |
SELL
Payment of exercise price or tax liability
|
Direct | 4,143 Reduced 0.5% |
$176,119
$42.51 p/Share
|
Mar 31
2022 |
|
SAH
|
Heath Byrd
EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 3,382 Reduced 1.92% |
$143,769
$42.51 p/Share
|
Mar 31
2022 |
|
NVRO
|
Michael F Demane |
BUY
Grant, award, or other acquisition
|
Direct | 362 Added 0.89% |
-
|
Mar 31
2022 |
|
NVRO
|
Elizabeth H Weatherman |
BUY
Grant, award, or other acquisition
|
Direct | 273 Added 0.7% |
-
|
Mar 31
2022 |